Acetyldigitoxin

From WikiMD's WELLNESSPEDIA

(Redirected from Acigoxin)

A cardiac glycoside used in the treatment of heart conditions

Acetyldigitoxin

Acetyldigitoxin






























Acetyldigitoxin is a cardiac glycoside derived from the Digitalis plant, commonly used in the treatment of certain heart conditions. It is a derivative of digitoxin, with an acetyl group added to its structure, which affects its pharmacokinetics and pharmacodynamics.

Chemical Structure[edit]

Structural formula of acetyldigitoxin

Acetyldigitoxin is a glycoside composed of a steroid nucleus with a lactone ring and a series of sugar moieties. The acetylation of digitoxin alters its solubility and absorption characteristics.

Pharmacology[edit]

Acetyldigitoxin works by inhibiting the sodium-potassium ATPase pump, leading to an increase in intracellular sodium. This increase in sodium promotes calcium influx via the sodium-calcium exchanger, enhancing cardiac contractility. This mechanism is beneficial in conditions such as congestive heart failure and certain types of arrhythmias.

Clinical Use[edit]

Acetyldigitoxin is used primarily in the management of heart failure and atrial fibrillation. Its long half-life allows for once-daily dosing, which can improve patient compliance. However, its narrow therapeutic index requires careful monitoring of blood levels to avoid toxicity.

Side Effects[edit]

Common side effects of acetyldigitoxin include nausea, vomiting, diarrhea, and confusion. More serious effects can include cardiac arrhythmias, which necessitate regular monitoring of patients on this medication.

Toxicity[edit]

Toxicity from acetyldigitoxin can occur due to its narrow therapeutic window. Symptoms of toxicity include gastrointestinal disturbances, visual changes, and severe arrhythmias. Treatment involves discontinuation of the drug and administration of digoxin-specific antibody fragments in severe cases.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.